Chief Executive Officer Appointment
Chief Executive Officer Appointment (final)
Additional Phase 1 data suggest MPL may inhibit MND
Additional Phase 1 data suggest MPL may inhibit motor neurone disease (final)
Cohort 3 Pharmacokinetics in MND Patients Completed
PharmAust Completes Cohort 3 Pharmacokinetics in MND Patients
Appendix 4C and Quarterly Update
Appendix 4C and Quarterly Update – June 2023
MND Trial Successfully Completes 3rd Patient Cohort
MND Trial Successfully Completes 3rd Patient Cohort (final)
Canine Trial Update
PAA Canine Study Update – July 2023_KA & SW
Results show MPL suppresses biomarkers associated with MND
Results show MPL suppresses biomarkers associated with MND (final)
Louie the Beagle surpasses one year on MPL
Louie the beagle surpasses one year on MPL (final)
MND Biomarkers and Pharmacodynamics Results
230704_MND Biomarkers and Pharmacodynamics Results (final)
Results of General Meeting
230630 Results of General Meeting